Titlebook: High Throughput Screening; Methods and Protocol William P. Janzen Book 20021st edition Springer Science+Business Media New York 2002

華而不實(shí)

Comparison of SPA, FRET, and FP for Kinase Assays,od of time with high sensitivity, accuracy, and reproducibility. Therefore, development of these new technologies has significantly accelerated the process of discovering drug leads for kinases. In this chapter, I will summarize and compare a number of technologies for development of homogeneous, high-throughput kinase assays.

使無(wú)效

Mindfulness

Management and Maintenance of High Throughput Screening Systems,labs is constantly increasing, the requirements for its continued maintenance are problems faced in all laboratories. An additional process that requires constant maintenance, but that is often forgotten, is management of personnel within the screening environment. This is, however, also an integral part of the efficient screening process.

并排上下

Book 20021st editiond in HTS and demonstrate how they can be applied generically. Writing to create precisely the introductory guidebook they wish had been available when they started in HTS, these expert seasoned authors illuminate the HTS process with richly detailed tutorials on the biological techniques involved, t

人類(lèi)

Book 20021st editionements of pharmacology, molecular biology, enzymology, and biochemistry that will ensure the identification of suitable targets and screens, and detail the technology necessary to mine millions of data points for meaningful knowledge.

CHOKE

滔滔不絕地說(shuō)

Cellular Assays in HTS, approaches have also been driven by the need to address complex, multi-component target classes that may not be feasible in biochemical assays. Finally, the increasingly combative intellectual property playing field, and the need to accelerate the drug discovery process have driven innovations in cell-based screening methodologies.

最低點(diǎn)

Design and Implementation of High Throughput Screening Assays,ing numbers of chemical compounds being produced through high-throughput chemistry initiatives. Many large companies study 100 targets or more each year, and in order to progress these targets, lead compounds must be found. Increasingly, pharmaceutical companies are relying on HTS as the primary engine driving lead discovery.

Congestion

,Homogeneous Techniques for Monitoring Receptor–Ligand Interactions,hese limitations, filtration-based radioligand binding assays were adequate to probe the kinetics of receptor-ligand interactions and to screen small libraries of compounds in search of receptor-binding antagonists. A number of reviews are available that described this methodology in detail (.,.).

Exclaim